Specialized medicine - private practice in ქ. ქუთაისი, იმერეთი. Address: საქართველო, ქალაქი ქუთაისი , ქუჩა ბუხაიძე , N 4, სართული 1.
GCAP internal — Sectors and enrichment.xlsx (2026-06-10)
| Ratio | 2022 | 2023 | 2024 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 100.0% | 100.0% | 100.0% |
| EBITDA Margin | 24.9% | 10.3% | 11.2% |
| EBITDAR | 417 | 186 | 180 |
| EBITDAR Margin | 26.4% | 11.8% | 14.3% |
| EBIT Margin | 22.6% | 6.8% | 6.4% |
| Net Profit Margin | 23.9% | -1.0% | -11.2% |
| Operating Expense % of Sales | 75.1% | 89.7% | 88.8% |
| Returns | |||
| Return on Assets (ROA) | 20.3% | -0.6% | -2.9% |
| Return on Equity (ROE) | 59.4% | -2.6% | -29.5% |
| ROIC [EBIT / Invested Capital] | 24.6% | 5.6% | 2.0% |
| Leverage & debt balances | |||
| Debt-to-Assets | 49.1% | 66.4% | 82.2% |
| Debt-to-Equity | 1.44x | 2.93x | 8.34x |
| Debt-to-EBITDA | 2.33x | 11.14x | 28.28x |
| Equity-to-Assets | 34.1% | 22.7% | 9.9% |
| Net Debt | 819 | 1,302 | 3,551 |
| Cash & Equivalents | 96 | 513 | 446 |
| Total Debt | 916 | 1,815 | 3,996 |
| Liquidity & working capital | |||
| Current Ratio | 2.68x | 1.93x | 1.11x |
| Quick Ratio | 2.68x | 1.93x | 1.11x |
| Cash Ratio | 0.17x | 1.11x | 0.52x |
| Total Current Assets | 1,551 | 893 | 941 |
| Total Current Liabilities | 579 | 462 | 849 |
| Inventory | N/A | N/A | N/A |
| Trade Receivables | 1,352 | 297 | 433 |
| Trade Payables | 231 | 196 | 330 |
| Net Working Capital | 972 | 431 | 92 |
| Net Working Capital % of Revenue | 61.6% | 27.2% | 7.3% |
| Trade Working Capital | 1,121 | 102 | 102 |
| Trade Working Capital % of Revenue | 71.0% | 6.4% | 8.1% |
| Change in Trade Working Capital | N/A | -1,019 | 0 |
| Turnover & efficiency | |||
| Inventory Turnover | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A |
| Receivables Turnover | 1.17x | 5.33x | 2.91x |
| Days Sales Outstanding (DSO) | 312.6 | 68.5 | 125.3 |
| Payables Turnover | N/A | N/A | N/A |
| Days Payable Outstanding (DPO) | N/A | N/A | N/A |
| Cash Conversion Cycle | 312.6 days | 68.5 days | 125.3 days |
| Asset Turnover | 0.85x | 0.58x | 0.26x |
| Cash flow & dividends | |||
| Operating Cash Flow | 39 | 417 | -67 |
| Free Cash Flow (OCF − Capex proxy) | 39 | 417 | -67 |
| Cash Conversion (OCF / EBITDA) | 10.1% | 256.0% | -47.5% |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →